carbidopa

FDA Drug Profile — Lodosyn

carbidopa is listed in the FDA National Drug Code directory with 3 NDC codes, marketed under brand name including Lodosyn. Available dosage forms: powder, tablet.

Drug Details

Generic Name
carbidopa
Brand Names
Lodosyn
Application Number
NDA017830
Sponsor
Fermion Oy
NDC Codes
3
Dosage Forms
POWDER, TABLET
Routes
ORAL
Active Ingredients
CARBIDOPA

Indications and Usage

1 INDICATIONS AND USAGE VYALEV is indicated for the treatment of motor fluctuations in adults with advanced Parkinson’s disease (PD). VYALEV is a combination of foscarbidopa (an aromatic amino acid decarboxylation inhibitor) and foslevodopa (an aromatic amino acid) indicated for the treatment of motor fluctuations in adults with advanced Parkinson’s disease. ( 1 )